ATE511551T1 - Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung - Google Patents

Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung

Info

Publication number
ATE511551T1
ATE511551T1 AT05741923T AT05741923T ATE511551T1 AT E511551 T1 ATE511551 T1 AT E511551T1 AT 05741923 T AT05741923 T AT 05741923T AT 05741923 T AT05741923 T AT 05741923T AT E511551 T1 ATE511551 T1 AT E511551T1
Authority
AT
Austria
Prior art keywords
tumor cells
aptamers selected
living tumor
aptamers
living
Prior art date
Application number
AT05741923T
Other languages
English (en)
Inventor
Bertrand Tavitian
Frederic Duconge
Domenico Libri
Franciscis Vittorio De
Laura Cerchia
Original Assignee
Commissariat Energie Atomique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commissariat Energie Atomique filed Critical Commissariat Energie Atomique
Application granted granted Critical
Publication of ATE511551T1 publication Critical patent/ATE511551T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05741923T 2004-03-17 2005-03-17 Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung ATE511551T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0402774A FR2867784B1 (fr) 2004-03-17 2004-03-17 Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications
PCT/FR2005/000656 WO2005093097A1 (fr) 2004-03-17 2005-03-17 Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications.

Publications (1)

Publication Number Publication Date
ATE511551T1 true ATE511551T1 (de) 2011-06-15

Family

ID=34896603

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05741923T ATE511551T1 (de) 2004-03-17 2005-03-17 Aus lebendigen tumorzellen ausgewählte aptamere und deren verwendung

Country Status (7)

Country Link
US (1) US20080227735A1 (de)
EP (1) EP1756305B1 (de)
JP (1) JP4807591B2 (de)
AT (1) ATE511551T1 (de)
CA (1) CA2559871A1 (de)
FR (1) FR2867784B1 (de)
WO (1) WO2005093097A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004092384A2 (en) 2003-04-17 2004-10-28 Affectis Pharmaceuticals Ag Means and methods for diagnosing and treating affective disorders
EP2078751A1 (de) * 2008-01-11 2009-07-15 Commissariat A L'energie Atomique Spezifische zur Unterdrückung der Zellmigration und -invasion durch Krebszellen erzeugte Aptamere, Verfahren zur Auswahl derartiger Aptamere und ihre Verwendung
CA2729602A1 (en) 2008-07-08 2010-01-14 Oncomed Pharmaceuticals, Inc. Notch1 receptor binding agents and methods of use thereof
EP2159286A1 (de) * 2008-09-01 2010-03-03 Consiglio Nazionale Delle Ricerche Verfahren zur Gewinnung von Oligonucleotid-Aptameren und Verwendungen damit
TWI535445B (zh) 2010-01-12 2016-06-01 安可美德藥物股份有限公司 Wnt拮抗劑及治療和篩選方法
AR080301A1 (es) 2010-02-24 2012-03-28 Immunogen Inc Anticuerpos e inmunoconjugados del receptor 1 de folato y sus usos
MX338932B (es) 2010-03-12 2016-05-06 Immunogen Inc Moleculas de union cd37 y sus inmunoconjugados.
ITRM20100537A1 (it) 2010-10-12 2012-04-12 Consiglio Nazionale Ricerche Aptamero inibitore del recettore tirosina chinasi axl per uso in terapia
FR2967423B1 (fr) 2010-11-12 2017-12-15 Commissariat Energie Atomique Ligand specifique de l'annexine 2
FR2969174B1 (fr) * 2010-12-16 2014-03-14 Commissariat Energie Atomique Ligand specifique de la proteine lar
CN102864150B (zh) * 2011-06-03 2013-08-21 湖南大学 一种可识别hcv ns5a蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
CN102229933A (zh) * 2011-06-03 2011-11-02 湖南大学 可识别hcv ns5a蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
CN102229932B (zh) * 2011-06-03 2013-02-27 湖南大学 可识别hcv e1e2蛋白的核酸适体、核酸适体的衍生物及其筛选方法和应用
CN102766693B (zh) * 2012-07-25 2013-08-28 湖南大学 可用于检测人肝癌细胞株smmc-7721的核酸适体及其筛选方法和应用
WO2014127484A1 (en) * 2013-02-21 2014-08-28 British Columbia Cancer Agency Branch Spike-in control nucleic acids for sample tracking

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6280932B1 (en) * 1990-06-11 2001-08-28 Gilead Sciences, Inc. High affinity nucleic acid ligands to lectins
US5580737A (en) * 1990-06-11 1996-12-03 Nexstar Pharmaceuticals, Inc. High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
JP2002510790A (ja) * 1998-04-06 2002-04-09 ブンセン ラッシュ ラボラトリーズ インコーポレーテッド 指向的進化バイオセンサ
DE60042021D1 (de) * 1999-07-29 2009-05-28 Gilead Sciences Inc Nukleinsäureliganden für den hepatozytischen wachstumsfaktor/dispersionsfaktor (hgf/sf) und seines c-met rezeptors
CA2450793A1 (en) * 2001-06-20 2002-12-27 Prochon Biotech Ltd. Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
ATE516366T1 (de) * 2002-07-25 2011-07-15 Archemix Corp Regulierte aptamer-therapeutika

Also Published As

Publication number Publication date
FR2867784A1 (fr) 2005-09-23
CA2559871A1 (fr) 2005-10-06
EP1756305B1 (de) 2011-06-01
EP1756305A1 (de) 2007-02-28
US20080227735A1 (en) 2008-09-18
JP2007529213A (ja) 2007-10-25
JP4807591B2 (ja) 2011-11-02
WO2005093097A1 (fr) 2005-10-06
FR2867784B1 (fr) 2006-06-09

Similar Documents

Publication Publication Date Title
CY1118714T1 (el) Υψηλης συγγενειας ανθρωπινα αντισωματα κατα του ανθρωπινου ενεργοποιουμενου απο πρωτεαση υποδοχεα-2
CY1119722T1 (el) Δημιουργια και περιγραφη πληρως ανθρωπινων θεραπευτικων αντισωματων λαμβανομενων μεσω hucal gold ειδικων για ανθρωπινό cd38
CY1111714T1 (el) Δεσμευτικες πρωτεϊνες αυξητικου παραγοντα ηπατοκυτταρων (hgf).
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
CY1109741T1 (el) Sns-595 και μεθοδοι χρησης αυτου
CY1113094T1 (el) Ανοσοσφαιρινες κατευθυνομενες εναντι nogo
CY1117833T1 (el) Νεες συνθεσεις και μεθοδοι για την αγωγη του καρκινου
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
EA201000016A1 (ru) Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями
EA201270100A1 (ru) Пиримидиноны в качестве ингибиторов pi3k
MX2009008430A (es) Anticuerpos anti-robo4 y sus usos.
EA201290894A1 (ru) Азетидиновые производные пиперидин-4-ила как ингибиторы jak1
EA200700321A1 (ru) Пиразолзамещённые аминогетероарильные соединения в качестве ингибиторов протеинкиназы
CY1112798T1 (el) Ενωσεις διαρυλυδαντοϊνης
PL2894162T3 (pl) Identyfikacja związanych z nowotworem antygenów do diagnozowania i leczenia
ATE540949T1 (de) Substituierte pteridine zur behandlung von entzündlichen erkrankungen
DE602006018709D1 (de) Estergebundene geminitensidverbindungen zur verwendung in der gentherapie
FR2867784B1 (fr) Aptameres selectionnes a partir de cellules vivantes tumorales et leurs applications
MY148484A (en) Caspase imaging probes
CY1116840T1 (el) Χρηση 24-norudca
EP1838330A4 (de) Behandlung von soliden tumoren
HUE046349T2 (hu) Kompozíciók rákos sejtek kezelésére, és ezek szintézise

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties